Publicaciones en las que colabora con EDURNE RUJAS DÍEZ (31)

2024

  1. Liposome-based peptide vaccines to elicit immune responses against the membrane active domains of the HIV-1 Env glycoprotein

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1866, Núm. 1

  2. On the antimicrobial properties and endurance of eugenol and 2-phenylphenol functionalized sol-gel coatings

    Heliyon, Vol. 10, Núm. 8

2023

  1. A multi-specific, multi-affinity antibody platform neutralizes sarbecoviruses and confers protection against SARS-CoV-2 in vivo

    Science translational medicine, Vol. 15, Núm. 697, pp. eadf4549

  2. Expression of a conserved sequence of SARS-CoV-2 for panβ-coronavirus vaccine development

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Modular adjuvant-free pan-HLA-DR-immunotargeting subunit vaccine against SARS-CoV-2 elicits broad sarbecovirus-neutralizing antibody responses

    Cell Reports, Vol. 42, Núm. 4

2022

  1. Dual Inhibition of Vacuolar-ATPase and TMPRSS2 Is Required for Complete Blockade of SARS-CoV-2 Entry into Cells

    Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 7

  2. Engineering pan-HIV-1 neutralization potency through multispecific antibody avidity

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 119, Núm. 4

  3. Functional Delineation of a Protein-Membrane Interaction Hotspot Site on the HIV-1 Neutralizing Antibody 10E8

    International journal of molecular sciences, Vol. 23, Núm. 18

  4. Molecular recognition of a membrane-anchored HIV-1 pan-neutralizing epitope

    Communications Biology, Vol. 5, Núm. 1

2021

  1. Focal accumulation of aromaticity at the CDRH3 loop mitigates 4E10 polyreactivity without altering its HIV neutralization profile

    iScience, Vol. 24, Núm. 9

  2. Lyophilized, thermostable Spike or RBD immunogenic liposomes induce protective immunity against SARS-CoV-2 in mice

    Science Advances, Vol. 7, Núm. 49

  3. Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease

    Scientific Reports, Vol. 11, Núm. 1

  4. Multivalency transforms SARS-CoV-2 antibodies into ultrapotent neutralizers

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Affinity for the Interface Underpins Potency of Antibodies Operating In Membrane Environments

    Cell Reports, Vol. 32, Núm. 7

  2. Cholesterol Constrains the Antigenic Configuration of the Membrane-Proximal Neutralizing HIV-1 Epitope

    ACS infectious diseases, Vol. 6, Núm. 8, pp. 2155-2168

  3. Structural characterization of the ICOS/ICOS-L immune complex reveals high molecular mimicry by therapeutic antibodies

    Nature Communications, Vol. 11, Núm. 1

  4. The Bilayer Collective Properties Govern the Interaction of an HIV-1 Antibody with the Viral Membrane

    Biophysical Journal, Vol. 118, Núm. 1, pp. 44-56

2019

  1. Molecular recognition of the native HIV-1 MPER revealed by STED microscopy of single virions

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Exposure of the HIV-1 broadly neutralizing antibody 10E8 MPER epitope on the membrane surface by gp41 transmembrane domain scaffolds

    Biochimica et Biophysica Acta - Biomembranes, Vol. 1860, Núm. 6, pp. 1259-1271

  2. Functional optimization of broadly neutralizing HIV-1 antibody 10E8 by promotion of membrane interactions

    Journal of Virology, Vol. 92, Núm. 8